Latest Stock Market News

A total of 20,742 shares changed hands on the counter till 10:35AM (IST)

Sectorally, selling was seen in metals, basic material, oil & gas, energy, and public sector stocks while buying was seen in auto, capital goods, IT and consumer discretionary segments. Metal stocks fell the most as several brokerages downgraded the sector after the government imposed export duties on iron ore and some steel intermediaries.

"We had already given exit calls in the small and midcaps segment, especially smallcaps, in the past 6-9 months because they were trading at higher valuations relative to the largecap peers. While selective companies in this space might be doing well, it is important that investors have ability to stomach volatility in small & midcaps. We would recommend selective mid-cap plays via PMS managers who have historically demonstrated their ability to identify solid and sustainable businesses."

“If you are holding cash, it is an asset class. In very volatile times, you protect capital. You can wait for the end of the day once markets have stabilised or once you can see a clear path but at the moment, you are being whipsawed on both sides in the markets. It is easy to just sit on the sidelines, let it play out a bit more.”

"For next few quarters – we expect esports to continue to build on the momentum of Q4 and with opening of offline events and growth of D2C biz with M&A of Wings and Planet Super Hero will be key drivers of growth in Nodwin while launch of new sports in US will be key driver of growth in SportsKeeda. We expect skill-based real money gaming to emerge as a growth driver on its own steam. M&A will drive scale of freemium as well as skill based real money gaming."

“Our overall view on the pharma sector remains neutral right now. Some of the larger companies are trading at an attractive valuation. For example, the likes of Sun Pharma, Cipla are doing well but I think the entire space will take some more time to come out of the woods.”

The stock, with a market capitalization of over Rs 1,700 crore, hit a record high of Rs 1,818 on May 20, 2022. The stock lost momentum after hitting a high, but experts feel that it is a good buy on dips stocks till Rs 1,650-1,330 levels.

Morgan Stanley has initiated coverage on SRF with an overweight stance with a target of Rs 2,757. It also initiated coverage on Aarti Industries (target Rs 954) and Navin Fluorine (Rs 4,562).

Majority of the crypto tokens were trading lower on Tuesday. BNB and Tron were the only two players rising, whereas Bitcoin and Ethereum were among the top losers. Avalanche and Solana dropped 5 per cent each.

Rossari Biotech Ltd., incorporated in the year 2009, is a Small Cap company (having a market cap of Rs 4931.95 Crore) operating in Chemicals sector.